Global pharma giant GlaxoSmithKline Pharmaceuticals Ltd received an income tax refund of ₹222.23 crore for the assessment year 2022-23, following an order issued by the Income Tax Department on Tuesday.
Global healthcare major informed in regulatory filings of an Income Tax Order for Assessment Year 2022-23 issuing income tax refund of Rs 222.23 cr including interest.
GlaxoSmithKline Pharmaceuticals declared a 37.8% year-on-year (YoY) increase in net profit to Rs.182.3 crore in the first quarter ended June 30, 2024. GlaxoSmithKline’s net profit in the same quarter was Rs.132.3 crore while revenue rose by 7% to Rs.814.7 crore from Rs.761.7 crore in the same period last year
UP CM Yogi Adityanath Marks Veer Bal Diwas At Kirtan Samagam, Hails Sikh Gurus’ Legacy Of Sacrifice
VIDEO: Virat Kohli Fans Climb Trees, Water Tanker To Watch Delhi Match After BCCI Allows No Spectators
.jpeg)
Western Railway Extends Dadar–Bhusaval Special Trains Till February 2026 To Meet Rising Passenger Travel Demand
BMC Elections 2026: Over 9,000 Nomination Forms Distributed As Poll Panel Extends Voter List Deadlines
